Traditional Chinese medicine stocks Dali Pharmaceutical Co.Ltd(603963) fell by the word limit at the opening , pulled up and turned red strongly near noon, and closed up and stopped until the closing. They won the quadruple board strongly and staged an amazing scene of “Earth sky board” .
As early as March 9, Dali Pharmaceutical Co.Ltd(603963) had staged a similar trend, and now it is “doing the same”.
The stock price has increased by 103.4% in the past two months.
Judging from the traditional Chinese medicine sector to which Dali Pharmaceutical Co.Ltd(603963) belongs, has ranked third in the year to date increase , second only to Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) and Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) .
What’s behind the crazy influx of funds in and Dali Pharmaceutical Co.Ltd(603963) the data of one-day list released after hours showed that , the net sales of funds in the dragon and tiger list were 7.718 million yuan the Lhasa business position of China stock market news, known as the “retail investor base”, listed four seats well-known hot money Dongguan Securities Beijing Branch and East Asia Qianhai securities Jiangsu Branch ranked third and first.
the data of three-day list released after hours of Dali Pharmaceutical Co.Ltd(603963) shows that , the capital of the dragon and tiger list has been sold for 1.1475 million yuan the Lhasa business position of China stock market news, known as the “retail base”, sells five seats well-known hot money East Asia Qianhai securities Jiangsu Branch ranks one for buy and one for sell; Dongguan Securities Beijing Branch ranked fifth.
Dali Pharmaceutical Co.Ltd(603963) latest announcement: Xingnaojing injection, the company’s product, is proposed to be purchased by Guangdong alliance Qingkailing and other proprietary Chinese medicines.
According to public information, Dali Pharmaceutical Co.Ltd(603963) main business is the production and sales of Chinese and Western medicine injections.
It is reported that the main products of Dali Pharmaceutical Co.Ltd(603963) , Xingnaojing injection and Shenmai injection, are recommended by the National Health Protection Committee and the State Administration of traditional Chinese medicine in the sixth, seventh, eighth and ninth edition of the New Coronavirus pneumonia diagnosis and treatment program, .
In terms of news, recently, who said: traditional Chinese medicine can effectively treat covid-19 pneumonia , reduce the conversion of mild and common cases to severe cases, shorten the virus clearance time, encourage Member States to consider absorbing traditional Chinese Medicine .
On January 29, Dali Pharmaceutical Co.Ltd(603963) released the performance forecast. The net profit of 2021 was – 45 million yuan to – 40 million yuan .
It is worth noting that the seller’s organization has little interest in Dali Pharmaceutical Co.Ltd(603963) and company has not covered since its listing on September 22, 2017.
